GO:0050805 negative regulation of synaptic transmission: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0050805 (negative regulation of synaptic transmission) describes any process that stops, prevents, or reduces the frequency, rate, or extent of communication from a neuron to a target cell across a synapse.
• Presynaptic calcium signaling, CaMKII activity, and BK channel function are core mechanisms that tune neurotransmitter release and can suppress synaptic transmission.
• Cell adhesion molecules such as CAR act as negative regulators of synaptic transmission, showing that structural proteins directly constrain synaptic strength.
• Energy supply is a limiting factor for synapses, and metabolic disruption in astrocytes can impair hippocampal synaptic plasticity and excitatory transmission.
• Disease-linked regulators such as DEPDC5 and microRNAs such as miR-186-5p modulate excitatory synaptic strength and network activity, linking GO:0050805 to neurological and psychiatric conditions.
• CRISPR knockout, point-mutation, knock-in, and overexpression models allow causal testing of candidate negative regulators of synaptic transmission in neurons and animal models.
Description
Synaptic transmission is the fundamental process by which neurons communicate with target neurons, muscles, or secretory cells across a synapse. GO:0050805, negative regulation of synaptic transmission, captures the biological processes that stop, prevent, or reduce the frequency, rate, or extent of this communication. This term is essential for understanding how neural circuits maintain stability, avoid runaway excitation, and adapt to changing physiological demands. Researchers study this process because disruptions in the balance between excitation and inhibition underlie many neurological and psychiatric disorders, and because synaptic transmission is one of the most energy-demanding activities in the brain. Presynaptic mechanisms, including calcium-dependent signaling and ion channel activity, are central to how neurotransmitter release is suppressed or tuned. At the same time, cell adhesion proteins and extracellular interactions can act as negative regulators that constrain synaptic strength. More recent work has linked metabolic and glial signals, such as astrocytic cholesterol deficiency, to impaired hippocampal synaptic plasticity and excitatory synaptic transmission, showing that negative regulation of synaptic transmission is not confined to neurons. Disease-associated proteins such as DEPDC5 and microRNAs such as miR-186-5p further demonstrate that this process is dynamically regulated in both physiological and pathological states. Understanding GO:0050805 therefore requires integrating presynaptic biology, adhesion signaling, metabolic support, and disease-relevant regulators.
negative regulation of synaptic transmission At A Glance
| GO ID | GO:0050805 |
|---|---|
| GO term | negative regulation of synaptic transmission |
| Ontology | biological_process |
| Synonym | down regulation of synaptic transmission; down-regulation of synaptic transmission; downregulation of synaptic transmission; inhibition of synaptic transmission |
| Major function | Reduces the frequency, rate, or extent of communication from a neuron to a target cell across a synapse |
| Biological context | Presynaptic calcium signaling, ion channel activity, cell adhesion, metabolic support, and disease-linked regulators |
| Related processes | Synaptic plasticity, excitation-inhibition balance, neuronal network activity |
| Research relevance | Target for neurological and psychiatric disease mechanisms, including cognitive dysfunction and chronic stress models |
What Is GO:0050805?
GO:0050805, negative regulation of synaptic transmission, is defined as any process that stops, prevents, or reduces the frequency, rate, or extent of synaptic transmission, the process of communication from a neuron to a target (neuron, muscle, or secretory cell) across a synapse. In practical terms, it includes molecular and cellular events that dampen neurotransmitter release, reduce postsynaptic responsiveness, or otherwise weaken synaptic communication. This regulation can occur presynaptically, for example through changes in calcium signaling or ion channel activity, or through cell adhesion molecules that constrain synaptic function. It can also be influenced by metabolic and glial support, as shown by astrocytic dysfunction leading to impaired hippocampal synaptic plasticity and excitatory transmission. The term is a biological process and is distinct from positive regulation of synaptic transmission, which enhances synaptic communication.
Why Is negative regulation of synaptic transmission Important in Cell Biology?
Negative regulation of synaptic transmission is critical for maintaining stable neural circuit function and preventing excessive excitation. Because synapses are among the most energy-demanding sites in the brain, their activity must be tightly controlled and supported by metabolic pathways. Disruption of this regulation can lead to impaired synaptic plasticity, cognitive dysfunction, and network instability, as seen when astrocytic cholesterol deficiency impairs hippocampal excitatory synaptic transmission. Disease-associated proteins such as DEPDC5 regulate the strength of excitatory synaptic transmission, linking this process to neurological disorders. In addition, microRNA-mediated regulation, such as miR-186-5p inhibition restoring synaptic transmission in a chronic stress model, highlights how negative regulation of synaptic transmission is dynamically controlled in psychiatric contexts. Understanding GO:0050805 therefore has direct implications for neurobiology, disease modeling, and therapeutic target discovery.
• Maintains excitation-inhibition balance and prevents runaway neuronal activity.
• Supports synaptic plasticity and cognitive function, as shown by hippocampal studies.
• Links metabolic and glial support to synaptic strength, since synapses are highly energy-demanding.
• Involved in disease mechanisms through regulators such as DEPDC5 in excitatory synaptic transmission.
• Modulated by microRNAs such as miR-186-5p in chronic stress and neuronal network activity.
• Provides targets for understanding neurological and psychiatric disorders.
• Can be studied using cell adhesion molecules such as CAR as negative regulators.
• Relevant to presynaptic mechanisms involving CaMKII and BK channels.
• Integrin-mediated regulation connects synaptic morphology and transmission.
• A2A receptor signaling influences striatal synaptic transmission and gene expression.
What Happens During negative regulation of synaptic transmission?
Presynaptic calcium signaling and neurotransmitter release
In simple terms: The amount of neurotransmitter a neuron releases depends on calcium signals inside the nerve terminal.
Presynaptic calcium signaling is a primary control point for synaptic transmission. CaMKII and BK channels regulate presynaptic function, and their activity can suppress or tune neurotransmitter release. Negative regulation of synaptic transmission often involves reducing calcium-dependent release probability or altering ion channel activity at the presynaptic terminal. This mechanism allows neurons to dampen communication without eliminating the synapse entirely.
Cell adhesion and structural constraints
In simple terms: Proteins that stick cells together can also put a brake on synaptic communication.
Cell adhesion molecules can act as negative regulators of synaptic transmission. The cell adhesion protein CAR is a negative regulator of synaptic transmission, demonstrating that structural proteins at the synapse directly constrain synaptic strength. Integrin-mediated regulation also influences synaptic morphology, transmission, and plasticity, showing that adhesion signaling is integrated with functional output. These findings indicate that negative regulation can arise from the physical and signaling architecture of the synapse.
Metabolic and glial support
In simple terms: Synapses need a lot of energy, and support cells help supply it; when that support fails, transmission is impaired.
Synapses are the brain's energy-demanding sites, and their function depends on metabolic support. Astrocytic cholesterol deficiency mediated by SREBP2 downregulation leads to postoperative cognitive dysfunction through impairment of hippocampal synaptic plasticity and excitatory synaptic transmission. This shows that negative regulation of synaptic transmission can result from disrupted glial metabolic support, not only from neuronal signaling changes.
Disease-linked regulators and microRNAs
In simple terms: Some proteins and small RNA molecules can turn down synaptic communication, and when they go wrong, disease can follow.
DEPDC5 regulates the strength of excitatory synaptic transmission by interacting with ubiquitin-specific protease 46, linking a disease-associated protein to negative control of synaptic strength. MiR-186-5p inhibition restores synaptic transmission and neuronal network activity in a model of chronic stress, indicating that microRNAs can suppress synaptic transmission under stress conditions. These examples show that negative regulation of synaptic transmission is dynamically controlled by diverse molecular regulators.
Receptor-mediated modulation
In simple terms: Receptors on neurons can change how strongly synapses respond, sometimes reducing transmission.
A2A receptor signaling is involved in striatal cellular functions, including regulation of gene expression, currents, and synaptic transmission. Such receptor-mediated modulation can contribute to negative regulation of synaptic transmission by altering neuronal excitability or neurotransmitter release. This highlights the role of G-protein-coupled receptor pathways in tuning synaptic communication.
Key Genes Involved in GO:0050805 negative regulation of synaptic transmission
The following genes and proteins have been experimentally linked to negative regulation of synaptic transmission or closely related regulatory mechanisms.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CaMKII | Presynaptic regulation of synaptic transmission | Regulates neurotransmitter release and plasticity |
| BK channels | Presynaptic ion channel controlling excitability | Modulates synaptic transmission |
| CAR | Cell adhesion protein acting as negative regulator | Directly constrains synaptic transmission |
| DEPDC5 | Regulates excitatory synaptic strength via USP46 interaction | Disease-linked regulator of synaptic transmission |
| USP46 | Ubiquitin-specific protease interacting with DEPDC5 | Modulates excitatory synaptic transmission |
| SREBP2 | Astrocytic transcription factor involved in cholesterol metabolism | Downregulation leads to impaired synaptic plasticity |
| miR-186-5p | MicroRNA regulating synaptic transmission | Inhibition restores synaptic transmission in chronic stress |
| Integrins | Adhesion receptors regulating synaptic morphology and transmission | Influence synaptic plasticity |
| A2A receptor | G-protein-coupled receptor in striatum | Regulates currents and synaptic transmission |
| Cholesterol | Membrane lipid supporting synaptic function | Deficiency impairs hippocampal synaptic transmission |
| USP46 | Deubiquitinase | Partners with DEPDC5 in synaptic regulation |
| SREBP2 | Lipid metabolism regulator | Astrocytic dysfunction affects synaptic plasticity |
| CaMKII | Calcium/calmodulin-dependent kinase | Presynaptic control of release |
| BK channels | Large-conductance calcium-activated potassium channels | Presynaptic excitability control |
| CAR | Coxsackievirus and adenovirus receptor | Negative regulator of synaptic transmission |
| Integrin | Extracellular matrix receptor | Regulates synaptic morphology and transmission |
| A2A receptor | Adenosine receptor | Modulates striatal synaptic transmission |
How Is negative regulation of synaptic transmission Regulated?
Negative regulation of synaptic transmission is itself regulated at multiple levels. Presynaptic calcium signaling through CaMKII and BK channels provides rapid, activity-dependent control of neurotransmitter release. Cell adhesion molecules such as CAR can constitutively or dynamically constrain synaptic strength. Metabolic and glial signals, including astrocytic SREBP2-dependent cholesterol metabolism, regulate synaptic plasticity and excitatory transmission. Disease-linked proteins such as DEPDC5 interact with ubiquitin-specific protease 46 to control excitatory synaptic strength. MicroRNAs such as miR-186-5p can suppress synaptic transmission under chronic stress, and their inhibition restores network activity. Receptor-mediated pathways, including A2A receptor signaling, also modulate synaptic transmission in specific brain regions. Together, these layers of regulation allow neurons to fine-tune synaptic communication in response to physiological and pathological cues.
negative regulation of synaptic transmission and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SREBP2 | Postoperative cognitive dysfunction; impaired hippocampal synaptic plasticity | Astrocyte-specific knockout or knockdown in rodent models |
| DEPDC5 | Neurological disorders with altered excitatory synaptic strength | Knockout or point-mutation neuronal cultures and animal models |
| miR-186-5p | Chronic stress and neuronal network dysfunction | MicroRNA inhibition in stress models |
| CAR | Synaptic transmission regulation | Knockout or overexpression in neurons |
| A2A receptor | Striatal dysfunction | Receptor knockout or pharmacological modulation |
Cognitive dysfunction and postoperative cognitive decline
Astrocytic cholesterol deficiency mediated by SREBP2 downregulation leads to postoperative cognitive dysfunction through impairment of hippocampal synaptic plasticity and excitatory synaptic transmission. This links negative regulation of synaptic transmission to clinical cognitive decline and suggests that metabolic support of synapses is critical for cognitive function.
Neurological disorders linked to DEPDC5
DEPDC5 regulates the strength of excitatory synaptic transmission by interacting with ubiquitin-specific protease 46. Dysregulation of this pathway may contribute to neurological conditions associated with altered synaptic strength, making DEPDC5 a candidate for mechanistic studies of negative regulation of synaptic transmission.
Chronic stress and psychiatric disorders
MiR-186-5p inhibition restores synaptic transmission and neuronal network activity in a model of chronic stress. This indicates that negative regulation of synaptic transmission by microRNAs contributes to stress-related neuronal dysfunction and that targeting such regulators may restore network activity.
Striatal dysfunction and receptor-mediated modulation
A2A receptor signaling regulates gene expression, currents, and synaptic transmission in the striatum. Altered A2A receptor function may affect negative regulation of synaptic transmission in striatal circuits, with implications for movement and psychiatric disorders.
From negative regulation of synaptic transmission-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene enhance synaptic transmission? | CRISPR knockout in primary neurons or cell lines |
| Does a disease-associated point mutation alter negative regulation? | Point-mutation knock-in via CRISPR |
| Does a specific protein domain mediate synaptic suppression? | Tagged knock-in for localization and interaction studies |
| Does overexpression of a regulator reduce synaptic transmission? | Overexpression models in neurons |
| Does astrocytic metabolic gene loss impair synaptic plasticity? | Astrocyte-specific knockout in rodent models |
| Does microRNA inhibition restore network activity? | MicroRNA inhibitor treatment in chronic stress models |
How to Study the negative regulation of synaptic transmission Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Patch-clamp electrophysiology | Synaptic currents and release probability | Testing negative regulators in neurons |
| Field potential recording | Population synaptic responses and plasticity | Hippocampal slice studies |
| Calcium imaging | Presynaptic calcium signals and activity | Presynaptic mechanism studies |
| Co-immunoprecipitation | Protein-protein interactions | Identifying DEPDC5-USP46 complexes |
| RNA sequencing | Gene expression changes | Profiling regulators of synaptic transmission |
| MicroRNA profiling | MicroRNA expression | Identifying miR-186-5p in stress models |
| Immunohistochemistry | Protein localization in tissue | Validating expression of synaptic regulators |
Electrophysiology
Patch-clamp and field potential recordings measure synaptic transmission strength, release probability, and plasticity. These methods are essential to determine whether a candidate gene negatively regulates synaptic transmission, as shown in studies of CAR and DEPDC5.
Calcium imaging
Calcium imaging reports presynaptic calcium dynamics and neuronal activity. Because presynaptic calcium signaling through CaMKII and BK channels controls neurotransmitter release, calcium imaging helps link molecular regulators to functional changes in synaptic transmission.
Molecular interaction assays
Co-immunoprecipitation, proximity labeling, and mass spectrometry identify protein partners such as DEPDC5 and USP46, revealing how negative regulators assemble into functional complexes.
Transcriptomics and microRNA profiling
RNA sequencing and microRNA profiling identify regulators such as miR-186-5p that suppress synaptic transmission under stress conditions, providing candidates for functional validation.
How CRISPR Can Be Used to Study GO:0050805 negative regulation of synaptic transmission
Knockout
CRISPR knockout of candidate genes such as CAR or DEPDC5 can test whether loss of function enhances synaptic transmission, thereby confirming a negative regulatory role. Knockout models are useful for establishing causality in neuronal cultures and animal models.
Point Mutation
Point-mutation knock-in can model disease-associated variants in genes such as DEPDC5 to determine whether specific residues are required for negative regulation of synaptic transmission. This approach links genetic variants to functional synaptic phenotypes.
Knock-in
Tagged knock-in of synaptic regulators allows visualization and interaction studies in native contexts, helping to define where and when negative regulation occurs. Knock-in of reporter or affinity tags supports proteomic and imaging workflows.
Overexpression
Overexpression of negative regulators such as miR-186-5p or CAR can suppress synaptic transmission and test sufficiency. Overexpression models complement knockout studies by demonstrating that increased levels of a regulator reduce synaptic strength.
How EDITGENE Supports negative regulation of synaptic transmission Research
Researchers studying negative regulation of synaptic transmission-related genes often need to determine whether a candidate gene is causally involved in dampening synaptic communication. Establishing causality requires precise genetic models that can remove, mutate, tag, or overexpress the gene of interest in relevant neuronal or glial contexts. EDITGENE provides end-to-end CRISPR services to generate such models and to support functional screening and bioinformatic analysis.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of synaptic transmission research.
Frequently Asked Questions About negative regulation of synaptic transmission
What is GO:0050805 negative regulation of synaptic transmission?
GO:0050805 is a Gene Ontology biological process term describing any process that stops, prevents, or reduces the frequency, rate, or extent of synaptic transmission, the communication from a neuron to a target cell across a synapse.
What genes are involved in negative regulation of synaptic transmission?
Genes and proteins experimentally linked to this process include CaMKII, BK channels, CAR, DEPDC5, USP46, SREBP2, miR-186-5p, integrins, and the A2A receptor.
How does presynaptic calcium signaling regulate synaptic transmission?
Presynaptic calcium signaling through CaMKII and BK channels controls neurotransmitter release and can suppress synaptic transmission.
What is the role of cell adhesion molecules in negative regulation of synaptic transmission?
Cell adhesion proteins such as CAR act as negative regulators of synaptic transmission, directly constraining synaptic strength.
How is negative regulation of synaptic transmission linked to disease?
Disruption of this process is linked to postoperative cognitive dysfunction, neurological disorders involving DEPDC5, chronic stress-related network dysfunction, and striatal dysfunction.
What experimental models are used to study negative regulation of synaptic transmission?
Common models include CRISPR knockout, point-mutation knock-in, tagged knock-in, and overexpression in neurons or glial cells, combined with electrophysiology and imaging.
Can microRNAs regulate synaptic transmission?
Yes, miR-186-5p inhibition restores synaptic transmission and neuronal network activity in a model of chronic stress, showing that microRNAs can suppress synaptic transmission.
What is the role of DEPDC5 in synaptic transmission?
DEPDC5 regulates the strength of excitatory synaptic transmission by interacting with ubiquitin-specific protease 46.
How do astrocytes influence synaptic transmission?
Astrocytic cholesterol deficiency mediated by SREBP2 downregulation leads to impaired hippocampal synaptic plasticity and excitatory synaptic transmission.
Why are synapses considered energy-demanding sites?
Synapses are among the brain's most energy-demanding sites, and their function depends on metabolic support, as reviewed in the literature.
Conclusion
GO:0050805, negative regulation of synaptic transmission, is a central biological process that controls how neurons communicate and maintain circuit stability. It integrates presynaptic calcium signaling, cell adhesion, metabolic and glial support, and disease-linked regulators such as DEPDC5 and miR-186-5p. Understanding this process is essential for neurobiology and for modeling neurological and psychiatric disorders. CRISPR-based knockout, point-mutation, knock-in, and overexpression models provide powerful tools to test causality and to identify new regulators of synaptic transmission.
References
- 1. Huang H et al.. 2026. Neuronal Cholesterol Deficiency Mediated by Astrocytic SREBP2 Downregulation Leads to Postoperative Cognitive Dysfunction Through Impairment of Hippocampal Synaptic Plasticity and Excitatory Synaptic Transmission.. Adv Sci (Weinh) 13(23):e19874 PMID: 41674341
- 2. Wang ZW. 2008. Regulation of synaptic transmission by presynaptic CaMKII and BK channels.. Mol Neurobiol 38(2):153-66 PMID: 18759010
- 3. Cerullo MS et al.. 2025. DEPDC5 regulates the strength of excitatory synaptic transmission by interacting with ubiquitin-specific protease 46.. Neurobiol Dis 212:106985 PMID: 40467011
- 4. Faria-Pereira A et al.. 2022. Synapses: The Brain's Energy-Demanding Sites.. Int J Mol Sci 23(7) PMID: 35408993
- 5. Wrackmeyer U et al.. 2019. The cell adhesion protein CAR is a negative regulator of synaptic transmission.. Sci Rep 9(1):6768 PMID: 31043663
- 6. Rodrigues B et al.. 2025. MiR-186-5p inhibition restores synaptic transmission and neuronal network activity in a model of chronic stress.. Mol Psychiatry 30(3):1034-1046 PMID: 39237722
- 7. Rohrbough J et al.. 2000. Integrin-mediated regulation of synaptic morphology, transmission, and plasticity.. J Neurosci 20(18):6868-78 PMID: 10995831
- 8. Schiffmann SN et al.. 2003. A2A receptor and striatal cellular functions: regulation of gene expression, currents, and synaptic transmission.. Neurology 61(11 Suppl 6):S24-9 PMID: 14663005
